Clinical study on serum microcystin levels and risk of nonalcoholic fatty liver disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027888

Enrollment

Unknown

Registered

2019-12-02

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

Normal group:N/A

NAFLD group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70, gender not limited. 2. Patients who are willing to participate in this case-control study and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Complicated with serious organic diseases or other liver diseases, such as liver tumors, viral hepatitis, autoimmune liver diseases, drug-induced liver diseases or hereditary liver diseases; (2) Pregnant women; (3) Suffering from psychosomatic diseases and unable to cooperate; (4) Patients who are considered by the researcher as not suitable for inclusion; (5) Patients who have been diagnosed with diabetes in the past.

Design outcomes

Primary

Measure	Time frame
gut microbiota;	—

Countries

China

Contacts

Public ContactShiming Yang

Department of Gastroenterology, Xinqiao Hospital

shimingyang@yahoo.com+86 13228686589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026